Recruiting
Prolymphocytic leukaemia+2
RecruitingRegistered drugNo placebo
Study on the Effectiveness of Entrectinib and Other Drug Combinations for Patients with Advanced Solid Tumors, Multiple Myeloma, or Non-Hodgkin Lymphoma
Registered drugNo placebo
- Disease:Prolymphocytic leukaemiaNon-Hodgkin's lymphoma+1
- Substances:AbemaciclibAlectinib+37
Countries:
The Netherlands
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Abemaciclib
- Sponsor:Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting

